Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
By Aakar Patel In 5 March 2021, the Press Information Bureau of the Government of India put out a statement...
Read moreDetails
By Dilip Cherian For a service that has perfected the art of surviving governments, political regimes, and the occasional scandal,...
Read moreDetails
Brazil, the largest South American country with a Leftist government, is poised to come within the orbit of the influence...
Read moreDetails
The Supreme Court stating on 5 October that it has not approved any modifications to Form 6 being used by...
Read moreDetails